Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06103136 · ClinicalTrials.gov registry record

Maestro 1.1 Post-Market Registry

A clinical trial of Surgery, sponsored by Moon Surgical.

Recruiting
Registry status
600
Enrollment target
12
Study locations

NCT06103136 is a study of Surgery that is actively recruiting participants, run by Moon Surgical. The registered enrollment target is 600 participants, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The trial reports 12 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06103136, a study of Surgery, is actively recruiting participants, sponsored by Moon Surgical.

RECRUITING
Registry status
600 participants
Enrollment target
12
Study locations

Study Summary

The objective of the study is to observe the real-life usage of the Maestro Platform for surgical assistance in laparoscopic surgery.

Conditions Studied

Interventions

  • DEVICE Laparoscopic surgery using the Maestro Platform

Study Locations (12)

Other

  • Chirec Delta - Auderghem
  • Polyclinique de Franche-Comté - Besançon
  • Clinique Bouchard - Marseille
  • Institut Arnault Tzanck - Saint-Laurent-du-Var
  • Clinique de l'Orangerie - Strasbourg

Florida

  • Lee Health - Fort Myers
  • Baptist Health - Jacksonville
  • Baptist Medical Center Beaches - Jacksonville
  • Orlando Veterans Affairs Medical Center - Orlando

Colorado

  • Rose Medical Center - Denver

Texas

  • Surgeon's Point ASC - Cedar Park

Alpes Maritimes

  • Hôpital Privé Arnault Tzanck - Mougin

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2023-09-29
Est. Completion 2025-12

Sponsor

Moon Surgical

1 total trials

What the Registry Record Tells You About NCT06103136

The ClinicalTrials.gov registry entry for NCT06103136 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,847-participant average among 120 other Surgery trials with a reported enrollment target (99% lower). The listed sponsor is Moon Surgical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Laparoscopic surgery using the Maestro Platform is the first listed.

NCT06103136 reports 12 study locations spanning 5 distinct geographic areas - top geographies include Other, Florida, Colorado.

Frequently Asked Questions

What is clinical trial NCT06103136 about?

NCT06103136 is a clinical study titled "Maestro 1.1 Post-Market Registry". The objective of the study is to observe the real-life usage of the Maestro Platform for surgical assistance in laparoscopic surgery.

What is the current status of trial NCT06103136?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2023-09-29. Estimated completion is 2025-12.

What conditions does trial NCT06103136 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT06103136?

The interventions under investigation include: Laparoscopic surgery using the Maestro Platform (DEVICE).

Who is sponsoring clinical trial NCT06103136?

This trial is sponsored by Moon Surgical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06103136 being conducted?

This trial has 12 study locations across Colorado, Florida, Texas, Alpes Maritimes. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.